Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

被引:0
作者
David Ben-Nathan
Orly Gershoni-Yahalom
Itzchak Samina
Yevgeny Khinich
Israel Nur
Orgad Laub
Ahuva Gottreich
Michael Simanov
Angel Porgador
Bracha Rager-Zisman
Nadav Orr
机构
[1] Ben Gurion University,The Shraga Segal Dept. of Microbiology and Immunology
[2] Kimron Veterinary Institute,undefined
[3] Department of Virology,undefined
[4] OMRIX Biopharmaceuticals,undefined
[5] Weizmann Science Park,undefined
[6] MDA National Blood Services,undefined
来源
BMC Infectious Diseases | / 9卷
关键词
West Nile Virus; Protective Efficacy; West Nile Virus Infection; Immunosuppressed Mouse; IVIG Preparation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 163 条
[1]  
Keller MA(2000)Passive immunity in prevention and treatment of infectious diseases Clin Microbiol Rev 13 602-614
[2]  
Stiehm ER(2004)Passive antibody therapy for infectious diseases Nat Rev Microbiol 2 695-703
[3]  
Casadevall A(1940)A neutrotropic virus isolated from the blood of a native of Uganda Am J Trop Med 20 471-492
[4]  
Dadachova E(2001)The relationships between West Nile and Kunjin viruses Emerg Infect Dis 7 697-705
[5]  
Pirofski LA(2001)The outbreak of West Nile virus infection in the New York City area in 1999 N Engl J Med 344 1807-1814
[6]  
Smithburn KC(2006)Long-term clinical and neuropsychological outcomes of West Nile virus infection Clin Infect Dis 43 723-730
[7]  
Hughes TP(2006)West Nile virus meningoencephalitis Nat Clin Pract Neurol 2 264-275
[8]  
Burke AW(2006)West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States Annu Rev Med 57 181-194
[9]  
Paul JH(2005)Epidemiology and transmission dynamics of West Nile virus disease Emerg Infect Dis 11 1167-1173
[10]  
Scherret JH(2006)CCR5 deficiency increases risk of symptomatic West Nile virus infection J Exp Med 203 35-40